News & Articles

JULABO USA announces the introduction of 'LucaVision' - a revolutionary new approach to customer service based on Augmented Reality from Atheer

The vDelivery service platform now offering free, expert support to get JULABO temperature control units up and running quickly, with more ways to connect virtually

New seed varieties introduced with high levels of CBG and a THC-level of below 0.2%

The new devices are designed to be ideal for applications sensitive to magnetic fields

This novel system could offer financial protection from fluctuations in market prices or changes in demand, and mitigate risks associated with an unreliable climate

Smart home technologies are an emerging market, with some households installing voice controlled appliances and smart security

Post-menopausal women with lower levels of the female sex hormone estrogen appear to be at higher risk of developing serious complications of COVID-19

Rice is the most widely consumed staple food source for a large part of the world’s population

AI applied to tumor microscopy images detects patterns of 167 different mutations and predicts patient survival in 28 cancer types

Professor Tatiana Perova & Professor Iouri Gounko (Trinity College) will be speaking at the Tyndall Bi-centenary online seminar

Astronomers are grappling with a puzzle that suggests dark matter is more evenly spread across the Universe than previously thought

Rapid antibody test receives CE mark for use by healthcare professionals

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

These complexes are designed for use by researchers in the School of Chemistry at the University of Bristol (UK) achieved using a DrySyn SnowStorm Reactor and DrySyn Splitter Manifold

A radical new method of imaging which harnesses artificial intelligence to turn time into visions of 3D space could help cars, mobile devices and health monitors develop 360-degree awareness

TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform

Scientists presented more than 45 abstracts that demonstrated the value of Bio-Rad’s Droplet Digital PCR (ddPCR) technology

87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting